CCR5 Co-receptor Antagonist class drugs

2 results
Hetero Labs Limited
Usage: Maraviroc tablets are used in combination with other antiretroviral agents to treat CCR5-tropic HIV-1 infection in patients aged 2 years and older, weighing at least 10 kg. It is not recommended for those with dual/mixed- or CXCR4-tropic HIV-1.
A2A Integrated Pharmaceuticals
Usage: Maraviroc is indicated for the treatment of CCR5-tropic HIV-1 infection in combination with other antiretroviral agents for adults and pediatric patients aged 2 years and older, weighing at least 10 kg. It is not recommended for patients with dual/mixed or CXCR4-tropic HIV-1.